Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 6.05
+0.04 (0.67%)
May 28, 2026, 10:54 AM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 4.9 billion as of May 27, 2026. Its market cap has increased by 11.87% in one year.
Market Cap
4.90B
Enterprise Value
4.66B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.05
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 4.90B, a decrease of -76.98%. That is a compound annual growth rate of -22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 4.90B | -18.78% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 6.73B |
| Laekna | 5.59B |
| Guangzhou Innogen Pharmaceutical Group | 5.46B |
| PegBio | 4.74B |
| Jacobio Pharmaceuticals Group | 4.01B |
| Beijing Luzhu Biotechnology | 3.87B |
| Shandong Boan Biotechnology | 3.73B |
| Mirxes Holding Company | 3.66B |